Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 218102, 8 pages
http://dx.doi.org/10.1155/2013/218102
Research Article

Alteration of 11 -Hydroxysteroid Dehydrogenase Type 1 and Glucocorticoid Receptor by Ethanol in Rat Liver and Mouse Hepatoma Cells

1Department of Pharmacology, School of Norman Bethune Medical Sciences, Jilin University, Changchun, Jilin 130021, China
2The 208th Hospital of the Chinese People’s Liberation Amry, Changchun, Jilin 130062, China
3Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E3P4, Canada

Received 16 April 2013; Accepted 7 May 2013

Academic Editor: Ji Li

Copyright © 2013 Zhaojie Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Christiansen, C. Thomsen, O. Rasmussen, C. Hansen, and K. Hermansen, “The acute impact of ethanol on glucose, insulin, triacylglycerol, and free fatty acid responses and insulin sensitivity in type 2 diabetes,” British Journal of Nutrition, vol. 76, no. 5, pp. 669–675, 1996. View at Google Scholar · View at Scopus
  2. N. Seike, M. Noda, and T. Kadowaki, “Alcohol consumption and risk of type 2 diabetes mellitus in Japanese: a systematic review,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 4, pp. 545–551, 2008. View at Google Scholar · View at Scopus
  3. B. Fromenty, N. Vadrot, J. Massart et al., “Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 1, pp. 23–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. B. Kahn, “Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance,” Cell, vol. 92, no. 5, pp. 593–596, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Groop, “Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion,” International Journal of Clinical Practice, pp. 3–13, 2000. View at Google Scholar · View at Scopus
  6. N. Chakarova, T. Tankova, I. Atanassova, and L. Dakovska, “Serum lipid and hsCRP levels in prediabetes—impaired fasting glucose (IFG) and impaired glucose tolerance (IGT),” Diabetes Research and Clinical Practice, vol. 86, no. 1, pp. 56–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Saini, “Molecular mechanisms of insulin resistance in type 2 diabetes mellitus,” World Journal of Diabetes, vol. 1, pp. 68–75, 2010. View at Google Scholar
  8. G. Bock, E. Chittilapilly, R. Basu et al., “Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: Role of increased rates of gluconeogenesis,” Diabetes, vol. 56, no. 6, pp. 1703–1711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Balage, J. Dupont, I. Mothe-Satney, S. Tesseraud, L. Mosoni, and D. Dardevet, “Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance,” Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 219–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kinote, J. A. Faria, E. A. Roman et al., “Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels,” Endocrinology, vol. 153, pp. 3633–3645, 2012. View at Google Scholar
  11. S. Renee Commerford, J. B. Ferniza, M. E. Bizeau, J. S. Thresher, W. T. Willis, and M. J. Pagliassotti, “Diets enriched in sucrose or fat increase gluconeogenesis and G-6-Pase but not basal glucose production in rats,” American Journal of Physiology—Endocrinology and Metabolism, vol. 283, no. 3, pp. E545–E555, 2002. View at Google Scholar · View at Scopus
  12. J. Lee and M. S. Kim, “The role of GSK3 in glucose homeostasis and the development of insulin resistance,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. S49–S57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Fan, H. Du, M. Zhang, Z. Meng, L. Chen, and Y. Liu, “Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1,” Molecular and Cellular Endocrinology, vol. 333, no. 1, pp. 62–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Zhang, X. Y. Lv, J. Li, Z. G. Xu, and L. Chen, “Alteration of 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes,” Molecular and Cellular Biochemistry, vol. 324, no. 1-2, pp. 147–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sengupta and B. Wasylyk, “Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2,” Genes and Development, vol. 15, no. 18, pp. 2367–2380, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Dembele, K. H. Nguyen, T. A. Hernandez, and B. L. G. Nyomba, “Effects of ethanol on pancreatic beta-cell death: interaction with glucose and fatty acids,” Cell Biology and Toxicology, vol. 25, no. 2, pp. 141–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. H. Nguyen, J. H. Lee, and B. L. Nyomba, “Ethanol causes endoplasmic reticulum stress and impairment of insulin secretion in pancreatic β-cells,” Alcohol, vol. 46, pp. 89–99, 2012. View at Google Scholar
  18. H. Kaneto, Y. Nakatani, D. Kawamori et al., “Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 782–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Teratani, H. Morimoto, K. Sakata et al., “Dose-response relationship between tobacco or alcohol consumption and the development of diabetes mellitus in Japanese male workers,” Drug and Alcohol Dependence, vol. 125, pp. 276–282, 2012. View at Google Scholar
  20. D. Sluik, H. Boeing, M. M. Bergmann et al., “Alcohol consumption and mortality in individuals with diabetes mellitus,” British Journal of Nutrition, vol. 108, pp. 1307–1315, 2012. View at Google Scholar
  21. C. Lipina, X. Huang, D. Finlay, E. J. McManus, D. R. Alessi, and C. Sutherland, “Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3,” Biochemical Journal, vol. 392, no. 3, pp. 633–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. McManus, K. Sakamoto, L. J. Armit et al., “Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis,” EMBO Journal, vol. 24, no. 8, pp. 1571–1583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. T. Murray, D. G. Campbell, N. Morrice et al., “Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3,” Biochemical Journal, vol. 384, no. 3, pp. 477–488, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Zhong, H. Zou, M. V. Semenov et al., “Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling,” Molecular BioSystems, vol. 5, no. 11, pp. 1356–1360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Frame and P. Cohen, “GSK3 takes centre stage more than 20 years after its discovery,” Biochemical Journal, vol. 359, no. 1, pp. 1–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. W. Tomlinson, E. A. Walker, I. J. Bujalska et al., “11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response,” Endocrine Reviews, vol. 25, no. 5, pp. 831–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Burén, S. A. Bergström, E. Loh, I. Söderström, T. Olsson, and C. Mattsson, “Hippocampal 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese zucker rat,” Endocrinology, vol. 148, no. 6, pp. 2716–2722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. I. Taylor, N. Frizzell, A. M. McKillop, P. R. Flatt, and V. A. Gault, “Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes,” Hormone and Metabolic Research, vol. 41, no. 12, pp. 899–904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Sui, J. Hu, J. Chen, P. Kuang, and D. Joyce, “Reversed effects of RU486 and anisomycin on memory retention of light exposure or corticosterone facilitation in the dark-incubated chicks,” Journal of Psychopharmacology, vol. 15, no. 4, pp. 287–291, 2001. View at Google Scholar · View at Scopus